Celldex Therapeutics, Inc. (CLDX) vs UroGen Pharma Ltd. (URGN)
A side-by-side comparison of Celldex Therapeutics, Inc. and UroGen Pharma Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLDX
Celldex Therapeutics, Inc.
$31.01HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
URGN
UroGen Pharma Ltd.
$41.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CLDX vs URGN
growth of $100 · dividends reinvested · last 9yCLDX -32.3% (-4.2%/yr)URGN +206.0% (+13.2%/yr)URGN compounded faster over this window
CLDX URGN
CLDX vs URGN: by the numbers
- •CLDX is the larger company ($2.06B vs $2.02B market cap).
- •Both run net losses; URGN's is the smaller (-51.73% vs -268385.71% net margin).
- •URGN grew revenue faster over the past five years (42.66% vs -58.05% CAGR).
Metrics side by side
Valuation
| Metric | CLDX | URGN |
|---|---|---|
| P/S ratio | 18419.87 | 10.70 |
| P/B ratio | 2.89 | N/A |
Profitability
| Metric | CLDX | URGN |
|---|---|---|
| Gross margin | 100.00% | 90.85% |
| Operating margin | -19160.00% | -113.73% |
| Net margin | -268385.71% | -51.73% |
| ROE | -42.07% | N/A |
| ROIC | -45.19% | -34.96% |
Growth (annualized)
| Metric | CLDX | URGN |
|---|---|---|
| Revenue CAGR (5Y) | -58.05% | 42.66% |
| Total return CAGR (5Y) | -10.28% | 20.32% |
Frequently asked
- Which has grown faster, CLDX or URGN?
- Over the past five years, URGN grew revenue faster — CLDX at a -58.05% CAGR versus URGN at 42.66%.
- How have CLDX and URGN total returns compared?
- Over the past 5 years, CLDX delivered -10.28% and URGN delivered 20.32% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Celldex Therapeutics ROEUroGen Pharma ROECelldex Therapeutics operating marginUroGen Pharma operating marginCelldex Therapeutics revenue growthUroGen Pharma revenue growthCelldex Therapeutics free cash flowUroGen Pharma free cash flow
Celldex Therapeutics & UroGen Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.